EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study

M Del Monte iD, S Kaleci, J Chester, V Zerbato iD, M Remitti, A Tili, A Dessilani, I Baldisserotto, S Esperti, M D Di Trapani, G Orlando, S Casolari iD und 11 weitere

Journal of Antimicrobial Chemotherapy · 03.09.2025 · 80 (9) · 2466-2473

DOI: 10.1093/jac/dkaf242 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 22.07.2025. Verfasst von M Del Monte und 22 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, Enterococcus faecium, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Conflicting results exist about mortality risk of infections caused by vancomycin-susceptible Enterococcus faecium (VSEfm) and vancomycin-resistant Enterococcus faecium (VREfm). Our aim was to compare risk factors and clinical outcomes among patients with VSEfm and VREfm bloodstream infections (BSIs).

Methods

A retrospective, multicentre, cohort study enrolled consecutive adult patients with VSEfm and VREfm BSI diagnosis between 2018–2022. Primary outcomes were 30-day-attributable and 30-day-overall mortality. Multivariable analysis propensity-weighted adjusted for timing to active therapy, Pitt Bacteremia Score (PBS) and Charlson Comorbidity Index (CCI) were performed to identify variables independently associated with 30-day mortality.

Results

Overall, 446 patients were enrolled: 140 (31.4%) VREfm and 306 (68.6%) VSEfm. Comparatively, VREfm patients more frequently received inappropriate antibiotic therapy, had higher sequential organ failure assessment, PBS and BSI relapses. 30-day-attributable and 30-day-overall mortality did not differ significantly between the two groups. Independent risk factors for 30-day attributable mortality were age (HR 1.04, CI95%, 1.00–1.08, P = 0.022), corticosteroid therapy (HR 3.05, CI95%, 1.24–7.47, P = 0.014) and septic shock (HR 9.10, CI95%, 3.80–21.79, P≤0.001), and overall mortality were age (HR 1.04, CI95%, 1.02–1.05, P≤0.001.), chronic liver failure (HR 1.67, CI95%, 1.02–2.75, P = 0.04) and haematological disease (HR 2.25, CI95%, 1.28–3.94, P = 0.005). Vancomycin resistance is not an independent risk factor for mortality when data are adjusted for confounding factors.

Conclusions

Adjusted analyses for time to active antibiotic therapy suggest that vancomycin resistance is not an independent risk factor for overall or attributable mortality among patients with Enterococcus faecium BSI. Independent risk factors identified in this study were exclusively comorbidities, severity and corticosteroids use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacteremiaEnterococcus faeciumGram-Positive Bacterial InfectionsVancomycin ResistanceVancomycin-Resistant EnterococciAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPropensity ScoreRetrospective StudiesRisk FactorsVancomycin

Substanzen

Anti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Infectious Diseases Unit, Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy.
  • Dermatology Unit, Department of Surgical, Medical, Dental and Morphological Science with Interest Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, Italy.
  • Clinical Microbiology Laboratory, University of Modena and Reggio Emilia, Modena, Italy.
  • Agenzia Sanitaria e sociale Regionale, Regione Emilia-Romagna, Bologna, Italy.

ORCID-Profile: M Del Monte, V Zerbato, S Casolari, A Bedini, E Franceschini, M Meschiari

Zitieren

APA

Del Monte, M., Kaleci, S., Chester, J., Zerbato, V., Remitti, M., Tili, A., Dessilani, A., Baldisserotto, I., Esperti, S., Di Trapani, M. D., Orlando, G., Casolari, S., Catania, A., Bedini, A., Franceschini, E., Sarti, M., Venturelli, C., Venturelli, I., Rofrano, L., …, & Meschiari, M. (2025). Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study. Journal of Antimicrobial Chemotherapy, 80(9), 2466-2473. https://doi.org/10.1093/jac/dkaf242

Vancouver

Del Monte M, Kaleci S, Chester J, Zerbato V, Remitti M, Tili A, et al. Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study. Journal of Antimicrobial Chemotherapy. 2025;80(9):2466-2473. doi:10.1093/jac/dkaf242

BibTeX
@article{DelMonte2025,
  author = {Del Monte, M and Kaleci, S and Chester, J and Zerbato, V and Remitti, M and Tili, A and Dessilani, A and Baldisserotto, I and Esperti, S and Di Trapani, M D and Orlando, G and Casolari, S and Catania, A and Bedini, A and Franceschini, E and Sarti, M and Venturelli, C and Venturelli, I and Rofrano, L and Ricchizzi, E and Di Bella, S and Mussini, C and Meschiari, M},
  title = {Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {9},
  pages = {2466--2473},
  doi = {10.1093/jac/dkaf242}
}
Kostenlos starten →